Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN), a global cell therapy leader, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Ying Huang, Ph.D., will deliver company updates at the event in San Francisco on January 14, 2025, at 3:45 p.m. PT. The presentation will be accessible via live audio webcast through Legend's Investor Relations website section, with a replay available approximately 48 hours after the event.

News Market Reaction – LEGN

+0.15%

+0.15% Session move

In the trading session that priced this news, LEGN gained 0.15%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest company updates at the 43^rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Tuesday, January 14, 2025, at 3:45 p.m. PT.

Investors and other interested parties can access the live audio webcast through the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.

About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at https://legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.

INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com

PRESS CONTACT:
Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com

FAQ

When is Legend Biotech (LEGN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Legend Biotech is presenting on Tuesday, January 14, 2025, at 3:45 p.m. PT in San Francisco, CA.

How can investors access Legend Biotech's (LEGN) J.P. Morgan Healthcare Conference presentation?

Investors can access the live audio webcast through the Investor Relations section of Legend Biotech's website.

When will the replay of Legend Biotech's (LEGN) J.P. Morgan presentation be available?

The webcast replay will be available approximately 48 hours after the live presentation.

Who is presenting for Legend Biotech (LEGN) at the 2025 J.P. Morgan Healthcare Conference?

Dr. Ying Huang, Legend Biotech's Chief Executive Officer, will present the company updates.

Which annual J.P. Morgan Healthcare Conference is Legend Biotech (LEGN) presenting at?

Legend Biotech is presenting at the 43rd Annual J.P. Morgan Healthcare Conference.